Abstract
Reversion mutations associated with PARP inhibitor resistance have been identified in tumors with RAD51C, RAD51D, and PALB2 as well as BRCA1 and BRCA2......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
